McKesson

J.P. Morgan is out with its report today on McKesson (NYSE: MCK), maintaining Overweight. In a note to clients, J.P. Morgan writes, "Our rating on McKesson is Overweight. We continue to point to the positive fundamental outlook for the drug distribution industry, and believe several key factors...